CD36 (Naka) sensitization with platelet-transfusion refractoriness in a liver transplant recipient [1]

Transplantation

Volumn 79, Issue 5, 2005, Pages 620-

  Ogata, Takashi ^a   Ohto, Hitoshi ^a   Yasuda, Hiroyasu ^a   Kawabata, Kinuyo ^a   Tsuchiya, Takao ^a   Saito, Takuro ^a   Gotoh, Mitsukazu ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; PREDNISOLONE; TACROLIMUS; THROMBOCYTE ANTIBODY;

ADULT; ANAMNESIS; ANTIBODY TITER; ANTIGEN DETECTION; BLEEDING; CASE REPORT; HUMAN; LETTER; LIVER DYSFUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; REFRACTORY THROMBOCYTOPENIA; SENSITIZATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; IMMUNOLOGY; MIDDLE AGED; THROMBOCYTE;

ANTIGENS, CD36; BLOOD PLATELETS; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PLATELET TRANSFUSION; THROMBOCYTOPENIA;

EID: 14944350998     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000146431.70743.89     Document Type: Letter

References (5)

1. Novotny VM. Prevention and management of platelet transfusion refractoriness. Vox Sang 1999; 76: 1.
2. a, on platelet membrane glycoprotein IV. Blood 1990; 75: 684.
3. Yamamoto N, Akamatsu N, Sakuraba H, et al. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood 1994; 83: 392.
4. a-negative platelet phenotype in African Americans is similar to that of Asians. Transfusion 1996; 36: 331.
5. a antibody alone. Vox Sang 2001; 81: 42.